linvoseltamab
regeneron
['linvoseltamab', 'multiplemyeloma', 'regeneron']
#regeneron reported #linvoseltamab (#bcmaxcd3) initial pivotal phase 2 data show clinically meaningful responses in patients with heavily pre-treated #multiplemyeloma #ash22 
Follow top-line development in the oncology commercial domain through our award winning intelligence service, 1stOncology.